Bottom line
How has DOCT performed?
As of Dec 31, 2024, DOCT returned +8.1% over the past year. Its best quarter was +6.1% and its worst −7.1%.
Updated Dec 31, 2024
DOCT annual returns by year
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| DOCT | +8.1% | +16.3% | −5.5% | +7.2% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in DOCT
$10,000 invested at the start of 2021 would have been worth about $12,700 by the end of 2024, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2024 | +8.1% | $12,732 |
| 2023 | +16.3% | $11,783 |
| 2022 | −5.5% | $10,133 |
| 2021 | +7.2% | $10,719 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| DOCT | +8.1% | — | — | +6.8% |
| Buffer / Defined Outcome median | +10.6% | +2.2% | +2.9% | — |
Source: Prospectus as of Dec 31, 2024; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending May 31, 2026, DOCT returned −2.49%, +5.20%, +1.97% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.